Recording Available: Truist AI Symposium Workshop – Data meets deep learning for in silico biologics with Absci

Have you ever wondered how AI can help discover better drugs, but get lost in the complexity? The Absci team (founder & CEO Sean McClain, CTO Matthew Weinstock, and Lead AI Scientist Joshua Meier) recently helped demystify this question and more in a fun conversation with Robyn Karnauskaus of Truist. Watch this video to learn more about how Absci is combining synthetic biology and AI to develop next-generation biologics. Now available on our YouTube channel: https://www.youtube.com/watch?v=VwN1ftgahWY